Need professional-grade analysis? Visit stockanalysis.com
$2.15B
323.53
348
N/A
Lotus Eye Hospital and Institute Limited (LOTUSEYE) trades on NSE in INR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at INR118.97, up 7.95% from the previous close.
Over the past year, LOTUSEYE has traded between a low of INR73.23 and a high of INR141.38. The stock has gained 61.1% over this period. It is currently 15.9% below its 52-week high.
Lotus Eye Hospital and Institute Limited has a market capitalization of $2.15B, with a price-to-earnings ratio of 323.53.
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
Side-by-side comparison against top Healthcare peers.